Evidence map›Paper›PMID 42366370›Full record

ArticleTrials2026

Adjunctive optical and magnetic stimulation for venous and mixed etiology leg ulcers: protocol for the NAZARÉ multicenter randomized controlled trial.

Sebastian Probst, Camille Saini, Alessio Stefanelli, André Frei, Ewa Klara Stuermer, Joachim Dissemond, Lars-Peter Kamolz, Benedikt Weber, Jean-Paul Lembelembe, Jürg Traber and 5 more

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in Trials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06528873 (NAZARÉ), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06528873 phase4recruitingnot on this map

NAZARÉ: Concurrent Optical and Magnetic Stimulation (COMS) for Treatment of Patients With Chronic Ulcers of Vascular Origin in a Real-world Setting Including Care at Patient's Home, a Prospective Randomized, Controlled, Assessor Blinded, Phase IV, Clinical Trial

TypeinterventionalSponsorSebastian ProbstRan2025 to 2026Enrolled122ConditionsVenous Leg Ulcer, Wound Heal, Magnetic Field ExposureArmsConcurrent optical and magnetic stimulation (COMS) treatment
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Sebastian ProbstSkin Ostomy and Wound Care, Geneva School of Health Science, HES-SO University of Applied Sciences and Arts, Avenue Champel 47, Geneva, Switzerland. sebastian.probst@hesge.ch.ORCID http://orcid.org/0000-0001-9603-1570
Camille SainiGeneva School of Health Science, HES-SO University of Applied Sciences and Arts, Geneva, Western Switzerland, Switzerland.ORCID http://orcid.org/0000-0003-2459-3034
Alessio StefanelliGeneva School of Health Science, HES-SO University of Applied Sciences and Arts, Geneva, Western Switzerland, Switzerland.ORCID http://orcid.org/0009-0009-0486-7414
André FreiGeneva School of Health Science, HES-SO University of Applied Sciences and Arts, Geneva, Western Switzerland, Switzerland.ORCID http://orcid.org/0009-0009-1378-4207
Ewa Klara StuermerComprehensive Wound Center, Department of Vascular Medicine, Translational Wound Research, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.ORCID http://orcid.org/0000-0003-4193-4857
Joachim DissemondDepartment of Dermatology, Venerology and Allergology, University of Duisburg-Essen, Essen, Germany.ORCID http://orcid.org/0000-0003-3893-328X
Lars-Peter KamolzUniversity Hospital Graz, Graz, Austria.
Benedikt WeberDepartment of Dermatology, Medical University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0002-7217-4590
Jean-Paul LembelembeAugustine Clinic, Malestroit, France.ORCID http://orcid.org/0000-0003-0405-2310
Jürg TraberVenenklinik Bellevue, Kreuzlingen, Switzerland.
Dieter MayerDepartment of Dermatology, University Hospital Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0001-5933-7749
Thomas ZehnderSpital Thun, Thun, Switzerland.
Dave BaerMedical Centre Cité Générations, Onex, Switzerland.
Claudio RuzzaOutpatient Wound-Care, Jura Hospital, Delémont, Switzerland.
Jürg HafnerDepartment of Dermatology, University Hospital Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-4571-1143

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVenous leg ulcers (VLUs) and VLUs associated with peripheral arterial disease (PAD) are common, recurrent, and costly to manage. Adjunctive biophysical therapies may improve healing outcomes when combined with standard of care (SOC). Concurrent optical and magnetic stimulation (COMS) has shown promising mechanistic and preliminary clinical results but there is a lack of robust randomized controlled trials (RCTs).

methodThis novel adjunct using concurrent optical and magnetic stimulation in a multicenter RCT in Europe (NAZARÉ) is a phase IV, post-market, multicenter, parallel-group, superiority randomized controlled trial conducted in Switzerland, France, Germany, and Austria. A total of 122 adults with VLU or mixed leg ulcers (ankle-brachial index > 0.5 and < 1.30 or ankle artery pressure > 60 mmHg), ulcer area 2-50 cm DISCUSSION: This trial will rigorously assess the effectiveness of COMS as an adjunct to standard care for venous and mixed leg ulcers. By targeting chronic wounds and using a pragmatic, multicenter design, it aims to generate robust, generalizable evidence. If effective, COMS could offer a non-invasive, accessible option to enhance healing outcomes and reduce the burden of chronic leg ulcers. TRIAL REGISTRATION NUMBER: ClinicalTrials.gov NCT06528873. Registred on 26 July 2024, https://register. CLINICALTRIALS: gov/prs/app/action/SelectProtocol?selectaction=Edit&sid=S000ERKB&uid=U0003LG4 .

Indexed as

Leg UlcerMagnetic Field TherapyVaricose UlcerWound HealingCombined Modality TherapyEquivalence Trials as TopicHumansMulticenter Studies as TopicQuality of LifeRandomized Controlled Trials as TopicTime FactorsTreatment OutcomeAdjunctive therapyBiophysical stimulationVenous leg ulcers

Identifiers

PMID42366370
PMCPMC13576315

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.